Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105547 · ClinicalTrials.gov registry record · Phase 3
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
A Phase 3 study, sponsored by Myrexis.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,600
- Enrollment target
NCT00105547 is a Phase 3 study that has completed, run by Myrexis. The registered enrollment target is 1,600 participants.
The verdict
NCT00105547, a Phase 3 study, has completed, sponsored by Myrexis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,600 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations during 18 months of dosing.
Interventions
- DRUG MPC-7869
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2005-02 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00105547
The ClinicalTrials.gov registry entry for NCT00105547 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Myrexis, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MPC-7869 is the first listed.
NCT00105547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00105547 about?
NCT00105547 is a clinical study titled "Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's". The purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations during 18 months of dosing.
What is the current status of trial NCT00105547?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,600 participants. The study started on 2005-02. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00105547?
The interventions under investigation include: MPC-7869 (DRUG).
Who is sponsoring clinical trial NCT00105547?
This trial is sponsored by Myrexis, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.